Related Experiment Video
Updated: Nov 30, 2025

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Pathophysiological mechanisms of liver injury in COVID-19
Alexander D Nardo1, Mathias Schneeweiss-Gleixner2, May Bakail3
1Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Insights
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) can cause liver injury in COVID-19 patients. This liver involvement may indicate disease severity and predict acute respiratory distress syndrome (ARDS).
Area of Science:
- Hepatology
- Virology
- Pulmonology
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has led to a global pandemic.
- Acute respiratory distress syndrome (ARDS) is a primary cause of mortality in COVID-19 patients.
- Hepatic involvement in COVID-19, while not causing liver failure without pre-existing conditions, correlates with disease severity and ARDS prognosis.
Purpose of the Study:
- To review the pathophysiological mechanisms of SARS-CoV-2 hepatic tropism.
- To discuss the spectrum of acute and potential long-term liver injury in COVID-19.
- To explore the relationship between COVID-19 and liver dysfunction.
Main Methods:
- Literature review of studies on COVID-19 and liver injury.
- Analysis of potential mechanisms including direct viral infection, systemic inflammation, hypoxia, and iatrogenic factors.
- Synthesis of current understanding of SARS-CoV-2's impact on the liver.
Main Results:
- SARS-CoV-2 can affect the liver through various pathways.
- Liver injury in COVID-19 ranges from direct infection to indirect effects of systemic illness.
- Hepatic involvement serves as a potential prognostic marker for ARDS development.
Conclusions:
- COVID-19 can lead to diverse forms of liver injury.
- Understanding SARS-CoV-2's hepatic tropism is crucial for patient management.
- Further research is needed to fully elucidate long-term hepatic consequences of COVID-19.
Abstract:
The recent outbreak of coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has resulted in a world-wide pandemic. Disseminated lung injury with the development of acute respiratory distress syndrome (ARDS) is the main cause of mortality in COVID-19. Although liver failure does not seem to occur in the absence of pre-existing liver disease, hepatic involvement in COVID-19 may correlate with overall disease severity and serve as a prognostic factor for the development of ARDS. The spectrum of liver injury in COVID-19 may range from direct infection by SARS-CoV-2, indirect involvement by systemic inflammation, hypoxic changes, iatrogenic causes such as drugs and ventilation to exacerbation of underlying liver disease. This concise review discusses the potential pathophysiological mechanisms for SARS-CoV-2 hepatic tropism as well as acute and possibly long-term liver injury in COVID-19.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...

